Publications
28
Citations
903
Est. group size
~1
Recurring co-author estimate
Active years
11
Publishing since 2016
Ahmed AbdelKhalek's work focuses on discovering and repurposing drugs to fight difficult bacterial infections, especially Clostridium difficile and antibiotic-resistant bacteria like vancomycin-resistant enterococci and Staphylococcus aureus. Much of this research involves screening existing FDA-approved drugs and testing new chemical compounds to find ones that can kill or block these pathogens. The work sits at the intersection of microbiology and medicinal chemistry, aimed at finding new treatments for hard-to-treat gut and antibiotic-resistant infections.
Publication output was relatively steady from 2017–2020 (3-5 papers/year) but has slowed considerably since 2021, averaging under 2 papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Editorial: Molecular mechanisms of plant responses to pathogens and pests in a changing climate
Molecular Biology Reports · 2026
- Screening for potent and selective anticlostridial leads among FDA-approved drugs
The Journal of Antibiotics · 2020
- Repurposing the Veterinary Antiprotozoal Drug Ronidazole for the Treatment of Clostridioides difficile Infection
International Journal of Antimicrobial Agents · 2020
- Aryl-alkyl-lysines: Novel agents for treatment of C. difficile infection
Scientific Reports · 2020
- Chemical Space Exploration around Thieno[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one Scaffold Led to a Novel Class of Highly Active <i>Clostridium difficile</i> Inhibitors
Journal of Medicinal Chemistry · 2019
- Discovery of Lipophilic Bisphosphonates That Target Bacterial Cell Wall and Quinone Biosynthesis
Journal of Medicinal Chemistry · 2019
- CCDC 1884213: Experimental Crystal Structure Determination
The Cambridge Structural Database · 2019
- Antibacterial and antivirulence activities of auranofin against Clostridium difficile
International Journal of Antimicrobial Agents · 2018
- Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
Scientific Reports · 2018
- Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE)
PLoS ONE · 2018
- Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci
International Journal of Antimicrobial Agents · 2018
- In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens
Current Pharmaceutical Design · 2017
- Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus
Scientific Reports · 2016
- In Vitro Antibacterial Activity of Rhodanine Derivatives against Pathogenic Clinical Isolates
PLoS ONE · 2016
- Scientific Reports×4
- PLoS ONE×4
- Journal of Medicinal Chemistry×3
- International Journal of Antimicrobial Agents×3
- The Cambridge Structural Database×3
- Christine H. Lee
Medicine · The Ohio State University
- Monika Fischer
Medicine · Indiana University
- David M. Aronoff
Medicine · Indiana University
- Huiping Xu
Medicine · Indiana University
- Christina Liscynesky
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile